MicroRNA function and dysregulation in bone tumors: the evidence to date
about
Biomarkers of Brain Damage and Postoperative Cognitive Disorders in Orthopedic Patients: An UpdateMicroRNAs as potential target in human bone and soft tissue sarcoma therapeuticsCombined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.Overexpression of miR‑199b‑5p inhibits Ewing's sarcoma cell lines by targeting CCNL1RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaMiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1.miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.Prognostic value of microRNAs in osteosarcoma: A meta-analysis.Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth.Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.Bone microenvironment signals in osteosarcoma development.MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1.microRNA and Bone Cancer.MicroRNAs and Fracture Healing.MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9.p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/β-catenin pathway.A polymorphism site in the pre‑miR‑34a coding region reduces miR‑34a expression and promotes osteosarcoma cell proliferation and migration.MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.
P2860
Q26784577-BEB0F4E9-BFBA-4256-B5FF-ED575B9DDD22Q28087258-5673AC61-65FB-4877-BAB9-F8BDA98C84D1Q33580714-E870EC4F-934B-4534-8B99-A626895023C6Q34339224-41FB4430-9756-4152-8687-5DCC227C8D3AQ34450694-17084310-3DF8-4F2A-A5DB-C40EA53E2E6AQ35919770-4A93073F-32A2-43EF-BBBD-C8F3F81919E1Q36131618-2BAA7CFC-4856-45E3-B28C-DE70F1B9374EQ36159870-948CB13C-2551-4F4E-B020-EE80DBD45229Q36261264-B0DA442A-BB4C-41DB-A0D7-8F5CE2D632AFQ37107802-C11D8867-0ACE-4956-B1CF-B83258883DC0Q37221246-E6F9A82B-83AD-4FFD-A480-0DF028F8BA19Q37702789-0DBA341A-282C-4A12-B3F6-3ED9CD91F246Q37745219-BAEF1F99-9BEF-46FB-8BF2-C1D11D112A7FQ38285398-7A00CDC9-0A82-4422-8F9C-656D0BCB8F2DQ38454980-A16B3DD1-E0E4-4E17-9B57-0F89837CD147Q38632868-892E6E0A-50C8-4881-903F-74FB2EF7125CQ38667026-CA783661-7437-49DC-9489-F557C77CD740Q38673947-94990084-4EC9-4B16-B754-A1C907B0BF4BQ38868180-5BF5411A-5176-4B5B-8614-974DA17C6A32Q38875125-B4A8EF5C-C7AC-4776-BCFB-440DF518AB0DQ38904937-03E6A6F4-36B8-49EE-9478-909F274C1965Q39985065-D0D2581C-976E-4AAE-A387-55EBCB13E58FQ41871223-2B414A92-67F7-4FE7-B0C2-A1461866EC8EQ46606607-2CF1EA24-6EAD-407E-9A52-08CAB504B7D6
P2860
MicroRNA function and dysregulation in bone tumors: the evidence to date
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA function and dysregulation in bone tumors: the evidence to date
@en
MicroRNA function and dysregulation in bone tumors: the evidence to date.
@nl
type
label
MicroRNA function and dysregulation in bone tumors: the evidence to date
@en
MicroRNA function and dysregulation in bone tumors: the evidence to date.
@nl
prefLabel
MicroRNA function and dysregulation in bone tumors: the evidence to date
@en
MicroRNA function and dysregulation in bone tumors: the evidence to date.
@nl
P2860
P356
P1476
MicroRNA function and dysregulation in bone tumors: the evidence to date
@en
P2860
P356
10.2147/CMAR.S53928
P407
P50
P577
2014-01-07T00:00:00Z